BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer's Disease (CTAD) conference, being held in San Diego December 1-4. Presentations will include data on long-term treatment and estimated time savings over 10 years, as well as safety and potential benefits of […]
NEW YORK, NY / ACCESS Newswire / November 18, 2025 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=178031&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
— Companies will support software interoperability and advance open standards for industrial simulation, collaborative design and AI infrastructure systems — Software portfolios of the three companies aid the creation of digital twins, improving building design, sustainability and equipment optimization across multiple industries, including buildings, grids and AI factories — Companies align with NVIDIA's vision for
https://mma.prnewswire.com/media/2825250/2026_Jeep_Recon.jpg — Built for adventure, the all-new 2026 Jeep® Recon is the only fully electric Trail Rated SUV, delivering rugged capability in a fully electrified form — Electrified and trail ready, the Jeep Recon delivers 650 horsepower, 620 lb.-ft. of instant torque and an estimated all-electric range of up to 250 miles, plus 0-60 mph
Pony.ai, a global leader in autonomous driving technology, today announces its fourth-generation (Gen-4) autonomous truck lineup, jointly developed with manufacturing partners including SANY Truck. The Gen-4 autonomous trucks system will utilize 100% automotive-grade components, reducing the bill-of-materials (BOM) cost per vehicle by approximately 70% compared to the previous generation. By leveraging the majority of components
— Total revenue of $455.8 million for the first half of 2025versus $143.5 million for the first half of 2024, an increase of 217.5% — Net income attributable toNutex Health Inc. of $3.5 million for the first half of 2025 versus net loss of $0.7 million for the first half of 2024, an increase of
NEW YORK, NY / ACCESS Newswire / November 18, 2025 / If you suffered a loss on your Marex Group plc (NASDAQ:MRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marex-group-plc-lawsuit-submission-form?prid=178033&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of November 2025 for its open-end exchange-traded funds and closed-end funds (“the Funds”). The ex-distribution date for all Open-End Funds is November 26, 2025. The ex-distribution date for all closed-end funds is November 28, 2025. Open-End
(TSX-V:TRR),(TSX-V:BGS), VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) — Terra Rossa Gold Ltd. (formerly, 0749116 B.C. Ltd.) (the “Company“) (TSXV: TRR) announces that further to its news release dated October 20, 2025, the Company has formally changed its name to “Terra Rossa Gold Ltd.” and has received confirmation from the TSX Venture Exchange (the
Purpose Investments Inc. Announces November 2025 Distributions GlobeNewswire November 19, 2025 TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of November 2025 for its open-end exchange-traded funds and closed-end funds (“the Funds”). The ex-distribution date for all Open-End Funds is November 26, 2025. The